Search results
Results from the Health.Zone Content Network
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. [8]
By Prerna Bedi. (Reuters) -British medical equipment maker Smith+Nephew retained its annual revenue and margin forecasts on Wednesday after posting a near 3% rise in revenue in the first quarter ...
Since becoming CEO in April 2011, Frenchman Olivier Bohuon has repositioned Smith and Nephew with acquisitions in advanced wound care and sports medicine, to reduce the company's dependence on the ...
Lim Kang Hoo ( Chinese: 林刚河, born 1956) is a Malaysian businessman and investor. [1] He is the founder, chairman and chief executive of Iskandar Waterfront Holdings and Ekovest Berhad. [2] Both corporations manage infrastructure construction projects, as well as mega property development. [3] Tan Sri Lim is also linked to other public ...
Vincent Tan Chee Yioun [2] ( Chinese: 陳志遠; pinyin: Chén Zhìyuǎn; Pe̍h-ōe-jī: Tân Chì-uán; born 1952) is a Malaysian Chinese businessman and investor. He is the founder of Berjaya Corporation Berhad, a diversified conglomerate listed on the Malaysian stock exchange. Besides holding stakes through the Berjaya Corporation group of ...
Smith & Nephew plc (NYSE: SNN) has acquired Engage Surgical, a provider of cementless unicompartmental (partial) knee systems. Engage Surgical is located in Orlando, Florida. The deal value of up ...
Bohuon was the chief executive of Smith & Nephew plc and Smith & Nephew Inc from April 2011 until May 2018. He served as the chief executive of Laboratoires Pierre Fabre from September 2010. Before that, he worked for Abbott Laboratories from 2003 to July 2010, rising to executive vice president, pharmaceutical products. [citation needed]
British medical products maker Smith+Nephew said weight-loss drugs could help previously ineligible overweight patients get approval for joint replacement surgery, playing down concerns about the ...